Comparative electrophysiological study of response to botulinum toxin type B in Japanese and Caucasians

被引:4
作者
Arimura, Kimiyoshi [1 ]
Arimura, Yumiko [1 ]
Takata, Yoshiharu [1 ]
Nakamura, Tomonori [1 ]
Kaji, Ryuji [2 ]
机构
[1] Kagoshima Univ, Grad Sch Med, Dept Neurol & Geriatr, Kagoshima 8908520, Japan
[2] Univ Tokushima, Sch Med, Dept Neurol, Tokushima, Japan
关键词
botulinum toxin type B; electrophysiology; extensor digitorum brevis muscle; M wave amplitude;
D O I
10.1002/mds.21807
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Ethnic differences in the muscle-relaxing effect of botulinum toxin type B (BTX-B) were examined by means of electrophysiological measurements in Japanese and Caucasian volunteers. This was a randomized, single-blinded, single-center study of 24 Japanese and 24 Caucasian healthy adult mate subjects in Japan. BTX-B (20 U, 100 U, or 500 U/0.2 mL) or placebo was administered to the extensor digitorum brevis (EDB) muscle in the left lower limb as a single dose (in each dose group, 6 subjects received the test drug and two received placebo). The inhibitory effect of BTX-B on the M wave amplitude of EDB muscle generated by stimulation of the deep peroneal nerve was measured frequently during 2 weeks after administration, and then at weeks 4 (day 28) and 12 (day 84). The inhibitory effect of BTX-B on the M wave amplitude of EDB muscle was dose-dependent in both Japanese and Caucasian subjects, and the dose-response curves were similar. These findings demonstrate that the muscle-relaxing effect of BTX-B in Japanese subjects is electrophysiologically similar to that in Caucasians. (C) 2007 Movement Disorder Society.
引用
收藏
页码:240 / 245
页数:6
相关论文
共 18 条
[1]   Botulinum toxin therapy, immunologic resistance, and problems with available materials [J].
Borodic, G ;
Johnson, E ;
Goodnough, M ;
Schantz, E .
NEUROLOGY, 1996, 46 (01) :26-29
[2]   The botulinum toxins in the treatment of cervical dystonia [J].
Brashear, A .
SEMINARS IN NEUROLOGY, 2001, 21 (01) :85-90
[3]   Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia [J].
Brin, MF ;
Lew, MF ;
Adler, CH ;
Comella, CL ;
Factor, SA ;
Jankovic, J ;
O'Brien, C ;
Murray, JJ ;
Wallace, JD ;
Willmer-Hulme, A ;
Koller, M .
NEUROLOGY, 1999, 53 (07) :1431-1438
[4]  
Brin MF, 1995, TREATMENT MOVEMENT D, P183
[5]   Efficacy and safety of repeated doses of botulinum toxin type B in type a resistant and responsive cervical dystonia [J].
Factor, SA ;
Molho, ES ;
Evans, S ;
Feustel, PJ .
MOVEMENT DISORDERS, 2005, 20 (09) :1152-1160
[6]   DEVELOPMENT OF RESISTANCE TO BOTULINUM TOXIN TYPE-A IN PATIENTS WITH TORTICOLLIS [J].
GREENE, P ;
FAHN, S ;
DIAMOND, B .
MOVEMENT DISORDERS, 1994, 9 (02) :213-217
[7]  
Hatheway CL., 1994, THERAPY BOTULINUM TO, P93
[8]   Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A [J].
Houser, MK ;
Sheean, GL ;
Lees, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (05) :577-580
[9]   RESPONSE AND IMMUNORESISTANCE TO BOTULINUM TOXIN INJECTIONS [J].
JANKOVIC, J ;
SCHWARTZ, K .
NEUROLOGY, 1995, 45 (09) :1743-1746
[10]   BOTULINUM TOXIN IN MOVEMENT-DISORDERS [J].
JANKOVIC, J .
CURRENT OPINION IN NEUROLOGY, 1994, 7 (04) :358-366